U.S. Stem Cell Clinics and International Businesses Are Registering For-Profit, Pay-to-Participate “Studies” on ClinicalTrials.gov
New perspective piece highlights the regulatory, ethical and scientific issues associated with U.S. “stem cell clinics” registering pay-to-participate stem cells studies on the NIH registry and database, ClinicalTrials.gov.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet – the regenerative medicine network
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.